NASDAQ : DERM
Journey Medical Corporation — Financial statements
Healthcare · Drug Manufacturers - Specialty & Generic · United States
Last price 5.17 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 145.92M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Journey Medical Corporation (DERM) reported revenue of 68.18M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Operating Revenue | 66.85M | 61.24M | 55.13M | 59.66M | 71.00M | 63.13M |
| Other Revenue | 1.33M | 619.00K | 1.00M | 19.52M | 2.67M | |
| Revenue | 68.18M | 61.86M | 56.13M | 79.18M | 73.67M | 63.13M |
| Cost of Revenue | 23.56M | 20.92M | 20.88M | 22.89M | 30.77M | 25.58M |
| Gross Profit | 44.62M | 40.93M | 35.26M | 56.29M | 42.89M | 37.55M |
| Selling, General & Admin | 42.91M | 44.37M | 40.20M | 43.91M | 59.47M | 39.83M |
| Research & Development | 495.00K | 480.00K | 9.86M | 7.54M | 10.94M | 16.56M |
| Amortization of Goodwill & Intangibles | 4.22M | 4.26M | 3.42M | 3.77M | ||
| Other Operating Expenses | -4.55M | |||||
| Operating Expenses | 47.63M | 49.11M | 48.93M | 55.22M | 70.41M | 56.39M |
| Operating Income | -3.01M | -8.17M | -13.68M | 1.07M | -27.52M | -18.84M |
| Interest Expense | -3.67M | -3.70M | -2.70M | -1.70M | -2.02M | -7.03M |
| Interest & Investment Income | 613.00K | 589.00K | 757.00K | 322.00K | 60.00K | 2.00K |
| Currency Exchange Gain (Loss) | -26.00K | -90.00K | -116.00K | -183.00K | -89.00K | |
| Other Non Operating Income (Expenses) | -447.00K | |||||
| EBT Excluding Unusual Items | -6.09M | -11.37M | -15.74M | -489.00K | -29.57M | -26.32M |
| Merger & Restructuring Charges | -6.50M | |||||
| Asset Writedown | -3.14M | |||||
| Other Unusual Items | 1.12M | -9.54M | ||||
| Pretax Income | -6.09M | -11.37M | -14.61M | -3.63M | -29.57M | -42.36M |
| Income Tax Expense | 15.00K | 60.00K | 61.00K | 221.00K | 63.00K | 1.63M |
| Net Income | -6.10M | -11.43M | -14.67M | -3.85M | -29.63M | -43.99M |
| Net Income to Common | -6.10M | -11.43M | -14.67M | -3.85M | -29.63M | -43.99M |
| Shares Outstanding (Basic) | 26.72M | 24.50M | 20.43M | 18.23M | 17.53M | 10.19M |
| Shares Outstanding (Diluted) | 26.72M | 24.50M | 20.43M | 18.23M | 17.53M | 10.19M |
| EPS (Basic) | -0.23 | -0.47 | -0.72 | -0.21 | -1.69 | -4.32 |
| EPS (Diluted) | -0.23 | -0.47 | -0.72 | -0.21 | -1.69 | -4.32 |
| Free Cash Flow | -7.49M | -12.44M | -9.13M | 5.24M | -13.53M | -2.18M |
| Free Cash Flow Per Share | -0.28 | -0.51 | -0.45 | 0.29 | -0.77 | -0.21 |
| Gross Margin | 65.45% | 66.17% | 62.80% | 71.09% | 58.23% | 59.48% |
| Operating Margin | -4.41% | -13.21% | -24.37% | 1.35% | -37.35% | -29.84% |
| Profit Margin | -8.95% | -18.48% | -26.14% | -4.87% | -40.22% | -69.68% |
| Free Cash Flow Margin | -10.99% | -20.11% | -16.26% | 6.62% | -18.37% | -3.45% |
| EBITDA | 1.22M | -3.91M | -10.25M | 4.84M | -23.24M | -16.37M |
| EBITDA Margin | 1.78% | -6.33% | -18.27% | 6.11% | -31.55% | -25.92% |
| D&A For EBITDA | 4.22M | 4.26M | 3.42M | 3.77M | 4.28M | 2.47M |
| EBIT | -3.01M | -8.17M | -13.68M | 1.07M | -27.52M | -18.84M |
| EBIT Margin | -4.41% | -13.21% | -24.37% | 1.35% | -37.35% | -29.84% |
| Revenue as Reported | 68.18M | 61.86M | 56.13M | 79.18M | 73.67M | 63.13M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 25.64M | 24.09M | 20.30M | 27.44M | 32.00M | 49.08M |
| Cash & Short-Term Investments | 25.64M | 24.09M | 20.30M | 27.44M | 32.00M | 49.08M |
| Receivables | 36.25M | 29.78M | 10.23M | 15.22M | 28.21M | 23.11M |
| Inventory | 8.16M | 9.62M | 14.43M | 10.21M | 14.16M | 9.86M |
| Prepaid Expenses | 2.74M | 3.38M | 3.21M | 3.59M | 3.31M | 2.44M |
| Total Current Assets | 72.78M | 66.87M | 48.18M | 56.45M | 77.68M | 84.49M |
| Property, Plant & Equipment | 65.00K | 111.00K | 199.00K | 101.00K | 189.00K | 89.00K |
| Other Intangible Assets | 25.51M | 27.61M | 31.86M | 20.29M | 27.20M | 12.55M |
| Other Long-Term Assets | 6.00K | 95.00K | 150.00K | |||
| Total Assets | 98.36M | 94.59M | 80.24M | 76.85M | 105.16M | 97.28M |
| Accounts Payable | 8.05M | 8.85M | 16.05M | 18.15M | 36.57M | 22.81M |
| Accrued Expenses | 29.72M | 26.24M | 15.23M | 16.49M | 16.27M | 20.09M |
| Short-Term Debt | 2.95M | 812.00K | ||||
| Current Portion of Long-Term Debt | 5.00M | 625.00K | 3.00M | 2.24M | 4.51M | |
| Current Portion of Leases | 69.00K | 101.00K | 83.00K | 99.00K | 83.00K | 98.00K |
| Current Income Taxes Payable | 70.00K | 60.00K | 53.00K | 35.00K | 8.00K | |
| Other Current Liabilities | 2.93M | 2.18M | 3.12M | 4.08M | 8.68M | 3.28M |
| Total Current Liabilities | 45.77M | 37.44M | 35.17M | 41.87M | 66.83M | 51.61M |
| Long-Term Debt | 20.47M | 25.28M | 24.88M | 14.62M | 21.24M | 3.63M |
| Long-Term Leases | 18.00K | 118.00K | 9.00K | 108.00K | ||
| Total Liabilities | 66.24M | 62.74M | 60.17M | 56.50M | 88.18M | 55.24M |
| Common Stock | 3.00K | 3.00K | 2.00K | 2.00K | 2.00K | 2.00K |
| Additional Paid-In Capital | 133.11M | 130.31M | 107.09M | 92.70M | 85.48M | 80.92M |
| Retained Earnings | -101.00M | -98.46M | -87.03M | -72.36M | -68.50M | -38.87M |
| Shareholders' Equity | 32.11M | 31.85M | 20.07M | 20.35M | 16.98M | 42.04M |
| Total Liabilities & Equity | 98.36M | 94.59M | 80.24M | 76.85M | 105.16M | 97.28M |
| Total Debt | 25.54M | 25.40M | 25.70M | 17.73M | 26.62M | 9.05M |
| Net Cash (Debt) | 102.00K | -1.31M | -5.40M | 9.71M | 5.38M | 40.03M |
| Net Cash Per Share | 0.00 | -0.05 | -0.26 | 0.53 | 0.31 | 3.93 |
| Filing Date Shares Outstanding | 28.22M | 27.33M | 23.10M | 19.93M | 17.83M | 17.32M |
| Total Common Shares Outstanding | 27.66M | 27.14M | 22.15M | 19.32M | 17.77M | 17.32M |
| Working Capital | 27.01M | 29.43M | 13.00M | 14.59M | 10.85M | 32.88M |
| Book Value Per Share | 1.16 | 1.17 | 0.91 | 1.05 | 0.96 | 2.43 |
| Tangible Book Value | 6.60M | 4.25M | -11.79M | 63.00K | -10.21M | 29.49M |
| Tangible Book Value Per Share | 0.24 | 0.16 | -0.53 | 0.00 | -0.57 | 1.70 |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -6.10M | -11.43M | -14.67M | -3.85M | -29.63M | -43.99M |
| Depreciation & Amortization | 4.32M | 4.35M | 3.52M | 3.77M | 4.37M | 2.56M |
| Other Amortization | 436.00K | 466.00K | 307.00K | 356.00K | 63.00K | 2.57M |
| Asset Writedown & Restructuring Costs | 3.14M | 13.82M | ||||
| Stock-Based Compensation | 6.05M | 6.29M | 6.10M | 2.61M | 4.42M | 2.47M |
| Provision & Write-off of Bad Debts | 54.00K | -211.00K | 516.00K | 435.00K | 284.00K | 48.00K |
| Other Operating Activities | -1.12M | 441.00K | 770.00K | 5.64M | ||
| Change in Accounts Receivable | -20.66M | -19.34M | 4.47M | 12.55M | -5.38M | 768.00K |
| Change in Inventory | 4.70M | 4.81M | -4.22M | 3.95M | 1.74M | -8.46M |
| Change in Accounts Payable | -4.71M | -7.20M | -2.10M | -18.42M | 14.34M | 20.39M |
| Change in Income Taxes | -71.00K | 10.00K | 7.00K | 18.00K | 27.00K | -91.00K |
| Change in Other Net Operating Assets | 8.49M | 9.82M | -1.92M | 244.00K | -4.55M | 2.10M |
| Operating Cash Flow | -7.49M | -12.44M | -9.13M | 5.24M | -13.53M | -2.18M |
| Sale (Purchase) of Intangibles | -15.00M | -5.00M | -20.00M | -10.00M | ||
| Investing Cash Flow | -15.00M | -5.00M | -20.00M | -10.00M | ||
| Short-Term Debt Issued | 28.00M | 5.00M | 7.00M | |||
| Long-Term Debt Issued | 10.00M | 15.00M | 19.76M | 9.54M | ||
| Total Debt Issued | 10.00M | 43.00M | 24.76M | 16.54M | ||
| Short-Term Debt Repaid | -30.95M | -2.86M | -6.19M | |||
| Long-Term Debt Repaid | -625.00K | -1.25M | -21.00M | -5.00M | -5.30M | |
| Total Debt Repaid | -625.00K | -1.25M | -51.95M | -7.86M | -11.49M | |
| Net Debt Issued (Repaid) | -625.00K | 8.75M | -8.95M | 16.90M | 5.05M | |
| Issuance of Common Stock | 12.92M | 16.93M | 8.29M | 4.62M | 142.00K | 32.54M |
| Other Financing Activities | -75.00K | -75.00K | -50.00K | -471.00K | -585.00K | -3.55M |
| Financing Cash Flow | 12.84M | 16.23M | 16.99M | -4.80M | 16.46M | 53.02M |
| Net Cash Flow | 5.35M | 3.79M | -7.13M | -4.56M | -17.08M | 40.84M |
| Free Cash Flow | -7.49M | -12.44M | -9.13M | 5.24M | -13.53M | -2.18M |
| Free Cash Flow Margin | -10.99% | -20.11% | -16.26% | 6.62% | -18.37% | -3.45% |
| Free Cash Flow Per Share | -0.28 | -0.51 | -0.45 | 0.29 | -0.77 | -0.21 |
| Levered Free Cash Flow | -5.46M | -8.35M | -18.48M | -4.79M | -24.51M | -4.25M |
| Unlevered Free Cash Flow | -3.61M | -6.51M | -17.10M | -4.09M | -23.31M | -2.43M |
| Cash Interest Paid | 3.23M | 3.24M | 2.01M | 1.13M | 993.00K | |
| Cash Income Tax Paid | 86.00K | 50.00K | 125.00K | 181.00K | 168.00K | 158.00K |
| Change in Working Capital | -12.25M | -11.90M | -3.77M | -1.66M | 6.19M | 14.71M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 142.82M | 209.22M | 81.68M | 106.61M | 34.11M | 89.63M |
| Enterprise Value | 142.71M | 209.57M | 80.29M | 84.99M | 24.63M | 109.08M |
| Last Close Price | 5.17 | 7.71 | 3.91 | 5.76 | 1.92 | 5.38 |
| Forward PE | 46.00 | 61.68 | ||||
| PS Ratio | 2.14 | 3.38 | 1.46 | 1.35 | 0.46 | 1.42 |
| PB Ratio | 4.45 | 6.57 | 4.07 | 5.24 | 2.01 | 2.13 |
| P/TBV Ratio | 22.10 | 49.26 | 1,692.20 | 3.04 | ||
| P/FCF Ratio | 20.34 | |||||
| P/OCF Ratio | 20.34 | |||||
| EV/Sales Ratio | 2.14 | 3.39 | 1.43 | 1.07 | 0.33 | 1.73 |
| EV/EBITDA Ratio | 119.92 | 17.57 | ||||
| EV/EBIT Ratio | 79.43 | |||||
| EV/FCF Ratio | 16.22 | |||||
| Debt / Equity Ratio | 0.80 | 0.80 | 1.28 | 0.87 | 1.57 | 0.21 |
| Debt / EBITDA Ratio | 19.32 | 3.59 | ||||
| Debt / FCF Ratio | 3.38 | |||||
| Net Debt / Equity Ratio | -0.00 | 0.04 | 0.27 | -0.48 | -0.32 | -0.95 |
| Net Debt / EBITDA Ratio | -0.08 | -0.33 | -0.53 | -2.01 | 0.23 | 2.45 |
| Net Debt / FCF Ratio | 0.01 | -0.10 | -0.59 | -1.85 | 0.40 | 18.36 |
| Asset Turnover | 0.76 | 0.71 | 0.71 | 0.87 | 0.73 | 0.85 |
| Inventory Turnover | 2.24 | 1.74 | 1.70 | 1.88 | 2.56 | 4.54 |
| Quick Ratio | 1.35 | 1.44 | 0.87 | 1.02 | 0.90 | 1.40 |
| Current Ratio | 1.59 | 1.79 | 1.37 | 1.35 | 1.16 | 1.64 |
| Return on Equity (ROE) | -23.77% | -44.03% | -72.60% | -20.64% | -100.39% | -168.12% |
| Return on Assets (ROA) | -2.09% | -5.84% | -10.88% | 0.73% | -16.99% | -15.79% |
| Return on Invested Capital (ROIC) | -9.85% | -27.88% | -75.75% | 9.62% | -237.22% | |
| Return on Capital Employed (ROCE) | -5.70% | -14.30% | -30.30% | 3.10% | -71.80% | -41.30% |
| Earnings Yield | -4.51% | -5.46% | -17.96% | -3.61% | -86.86% | -49.09% |
| FCF Yield | -5.13% | -5.95% | -11.17% | 4.92% | -39.68% | -2.43% |
| Buyback Yield / Dilution | -21.63% | -19.90% | -12.06% | -4.00% | -72.05% | 5.96% |